This content is machine translated Corona protection and skin health Mask dermatitis – expert tips for prophylaxis and treatment During the corona pandemic, an increase in facial skin lesions was observed due to the wearing of a mouth-nose protection. Wearing an FFP2 protective mask will continue to be recommended…
View Post 2 min This content is machine translated Breast Cancer Regulatory extension for anti-PD-1 therapy with pembrolizumab Swissmedic has granted a further marketing authorization for anti-PD-1 therapy with pembrolizumab. This can now be approved in combination with chemotherapy in Switzerland for the treatment of patients with locally…
View Post 3 min This content is machine translated Long-term management of psoriasis Biologics have improved the supply situation Psoriasis registries and care studies are an important source of data for evidence-based systems therapy. Convincing long-term data are now available, particularly for the anti-IL-17 and anti-IL-23 antibodies. These have also…
View Post 4 min This content is machine translated Iron deficiency Update anemia workup: what, when, and why? Iron deficiency anemia is common – especially in elderly patients with renal insufficiency or malnutrition. As a rule, a multifactorial process can be assumed. Therefore, a number of different causes…
View Post 2 min This content is machine translated Comorbidity Research Chronic urticaria: increased prevalence of mental disorders. According to a secondary analysis, almost one in three patients with chronic urticaria suffers from at least one mental disorder. Sleep-wake cycle impairments are most common, followed by anxiety disorders…
View Post 3 min This content is machine translated Relapsing-remitting multiple sclerosis (RRMS) New S1P1 modulator expands the therapeutic spectrum The selective sphingosine-1-phosphate receptor 1 (S1P1) modulator ponesimod has been approved in Switzerland since November 2021 for the treatment of relapsing-remitting multiple sclerosis (RRMS) with active disease. The approval is…
View Post 4 min This content is machine translated Ischemic stroke “Time is brain” – guideline recommendations for acute therapy. Worldwide, strokes are among the leading causes of mortality and morbidity. In a new edition of the S2e guideline on acute therapy of ischemic insults, recommendations are given on the…
View Post 2 min This content is machine translated Neoadjuvant treatment with T-VEC Preoperative immunotherapy improves prognosis in metastatic melanoma In a study involving dermatologists from the University Hospital Zurich, preoperative immunotherapy was shown to increase the likelihood of survival and a longer recurrence-free interval in melanoma patients. For patients,…
View Post 3 min This content is machine translated Intestinal germs and rheumatism How the microbiome influences disease propensity The human intestine is home to an entire ecosystem of bacteria, fungi, viruses and other microorganisms. Weighing up to two kilograms, this biocoenosis is virtually an organ within an organ…
View Post 3 min This content is machine translated Rosacea: new S2k guideline Phenotype-based classification for diagnostics and therapy Rosacea is perceived as bothersome by patients and can lead to stigmatization. The newly published S2k guideline explains the symptom-oriented classification according to phenotypes, explains how rosacea is differentiated from…
View Post 4 min This content is machine translated Thrombocytopenia New thrombopoietin receptor agonist available Avatrombopag is an effective and safe second-line treatment for adult patients with chronic immune thrombocytopenia (ITP). In addition, this thrombopoietin receptor agonist can be used in adults with chronic liver…
